Blockade of CD40L has been shown to inhibit autoantibody production and tissue inflammation in mice with autoimmune thyroid diseases and NOD mice with SS-like phenotypes, suggesting a critical role of the CD40-CD40L interaction in these diseases [143]. This evidence concerns the gene CD40LG and autoimmune thyroid disease.